BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 3140103)

  • 1. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
    Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum beta 2-microglobulin concentration and its removal in patients treated with continuous ambulatory peritoneal dialysis].
    Kubo H; Kawaguchi Y; Aizawa S; Morita T; Nakayama M; Wakabayashi Y; Watanabe S; Ogawa A; Sakai O
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):419-26. PubMed ID: 2198365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2 microglobulin in CAPD.
    Montenegro J; Martínez I; Saracho R; González R
    Adv Perit Dial; 1992; 8():369-72. PubMed ID: 1361825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
    Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D; Gower PE
    Nephrol Dial Transplant; 1988; 3(6):768-72. PubMed ID: 3147418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
    Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
    Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
    Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
    Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis-related amyloidosis in a large CAPD population.
    Catizone L; Viglietta G; Cocchi R; Dadone C; De Vecchi A; Giangrande A; Lindner G; Manili L; Querques M; Ramello A
    Adv Perit Dial; 1995; 11():213-7. PubMed ID: 8534708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
    Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
    Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodialysis-associated beta 2M amyloidosis: current controversies.
    Stein G; Sperschneider H; Fünfstück R; Ritz E
    Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S; Kraus AP; Jennings BR
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Catizone L; Cocchi R; Fusaroli M; Zucchelli P
    Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations and peritoneal loss of growth hormone and growth-hormone-binding protein activity in older adults undergoing continuous ambulatory peritoneal dialysis: comparison with haemodialysis patients and normal subjects.
    Kagan A; Zadik Z; Gertler A; Ulman M; Bar-Khayim Y
    Nephrol Dial Transplant; 1993; 8(4):352-6. PubMed ID: 8390011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.